{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T13:28:59Z","timestamp":1791379739904,"version":"4.3.3"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"21","license":[{"start":{"date-parts":[[2016,12,19]],"date-time":"2016-12-19T00:00:00Z","timestamp":1482105600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2016,12,19]],"date-time":"2016-12-19T00:00:00Z","timestamp":1482105600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2017,5,25]]},"DOI":"10.1038\/onc.2016.455","type":"journal-article","created":{"date-parts":[[2016,12,19]],"date-time":"2016-12-19T16:26:36Z","timestamp":1482164796000},"page":"3015-3024","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["PAX2 function, regulation and targeting in fallopian tube-derived high-grade serous ovarian cancer"],"prefix":"10.1038","volume":"36","author":[{"given":"D A","family":"Modi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R D","family":"Tagare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Karthikeyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Russo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Dean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D A","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D D","family":"Lantvit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J E","family":"Burdette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,12,19]]},"reference":[{"key":"BFonc2016455_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21332","volume":"66","author":"RL Siegel","year":"2016","unstructured":"Siegel RL, Miller KD, Jemal A . Cancer statistics, 2016. CA Cancer J Clin 2016; 66: 7\u201330.","journal-title":"CA Cancer J Clin"},{"key":"BFonc2016455_CR2","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1097\/PGP.0b013e3181f45f3e","volume":"30","author":"N Auersperg","year":"2011","unstructured":"Auersperg N . The origin of ovarian carcinomas: a unifying hypothesis. Int J Gynecol Pathol 2011; 30: 12\u201321.","journal-title":"Int J Gynecol Pathol"},{"key":"BFonc2016455_CR3","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1002\/path.1000","volume":"195","author":"JM Piek","year":"2001","unstructured":"Piek JM, van Diest PJ, Zweemer RP, Jansen JW, Poort-Keesom RJ, Menko FH et al. Dysplastic changes in prophylactically removed Fallopian tubes of women predisposed to developing ovarian cancer. J Pathol 2001; 195: 451\u2013456.","journal-title":"J Pathol"},{"key":"BFonc2016455_CR4","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1097\/01.pas.0000213335.40358.47","volume":"31","author":"DW Kindelberger","year":"2007","unstructured":"Kindelberger DW, Lee Y, Miron A, Hirsch MS, Feltmate C, Medeiros F et al. Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: Evidence for a causal relationship. Am J Surg Pathol 2007; 31: 161\u2013169.","journal-title":"Am J Surg Pathol"},{"key":"BFonc2016455_CR5","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1097\/01.pas.0000180854.28831.77","volume":"30","author":"F Medeiros","year":"2006","unstructured":"Medeiros F, Muto MG, Lee Y, Elvin JA, Callahan MJ, Feltmate C et al. The tubal fimbria is a preferred site for early adenocarcinoma in women with familial ovarian cancer syndrome. Am J Surg Pathol 2006; 30: 230\u2013236.","journal-title":"Am J Surg Pathol"},{"key":"BFonc2016455_CR6","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1038\/modpathol.2009.89","volume":"22","author":"PA Shaw","year":"2009","unstructured":"Shaw PA, Rouzbahman M, Pizer ES, Pintilie M, Begley H . Candidate serous cancer precursors in fallopian tube epithelium of BRCA1\/2 mutation carriers. Mod Pathol 2009; 22: 1133\u20131138.","journal-title":"Mod Pathol"},{"key":"BFonc2016455_CR7","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1002\/path.2761","volume":"222","author":"EY Chen","year":"2010","unstructured":"Chen EY, Mehra K, Mehrad M, Ning G, Miron A, Mutter GL et al. Secretory cell outgrowth, PAX2 and serous carcinogenesis in the Fallopian tube. J Pathol 2010; 222: 110\u2013116.","journal-title":"J Pathol"},{"key":"BFonc2016455_CR8","first-page":"625","volume":"3","author":"K Mehra","year":"2011","unstructured":"Mehra K, Mehrad M, Ning G, Drapkin R, McKeon FD, Xian W et al. STICS, SCOUTs and p53 signatures; a new language for pelvic serous carcinogenesis. Front Biosci (Elite Ed) 2011; 3: 625\u2013634.","journal-title":"Front Biosci (Elite Ed)"},{"key":"BFonc2016455_CR9","doi-asserted-by":"publisher","first-page":"20500","DOI":"10.18632\/oncotarget.3985","volume":"6","author":"SL Eddie","year":"2015","unstructured":"Eddie SL, Quartuccio SM, Oh E, Moyle-Heyrman G, Lantvit DD, Wei JJ et al. Tumorigenesis and peritoneal colonization from fallopian tube epithelium. Oncotarget 2015; 6: 20500\u201320512.","journal-title":"Oncotarget"},{"key":"BFonc2016455_CR10","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1593\/neo.11138","volume":"13","author":"AA Jazaeri","year":"2011","unstructured":"Jazaeri AA, Bryant JL, Park H, Li H, Dahiya N, Stoler MH et al. Molecular requirements for transformation of fallopian tube epithelial cells into serous carcinoma. Neoplasia 2011; 13: 899\u2013911.","journal-title":"Neoplasia"},{"key":"BFonc2016455_CR11","doi-asserted-by":"publisher","first-page":"7547","DOI":"10.1073\/pnas.1017300108","volume":"108","author":"AM Karst","year":"2011","unstructured":"Karst AM, Levanon K, Drapkin R . Modeling high-grade serous ovarian carcinogenesis from the fallopian tube. Proc Natl Acad Sci USA 2011; 108: 7547\u20137552.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFonc2016455_CR12","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1016\/j.ccr.2013.10.013","volume":"24","author":"R Perets","year":"2013","unstructured":"Perets R, Wyant GA, Muto KW, Bijron JG, Poole BB, Chin KT et al. Transformation of the fallopian tube secretory epithelium leads to high-grade serous ovarian cancer in Brca;Tp53;Pten models. Cancer Cell 2013; 24: 751\u2013765.","journal-title":"Cancer Cell"},{"key":"BFonc2016455_CR13","doi-asserted-by":"publisher","first-page":"3921","DOI":"10.1073\/pnas.1117135109","volume":"109","author":"J Kim","year":"2012","unstructured":"Kim J, Coffey DM, Creighton CJ, Yu Z, Hawkins SM, Matzuk MM . High-grade serous ovarian cancer arises from fallopian tube in a mouse model. Proc Natl Acad Sci USA 2012; 109: 3921\u20133926.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFonc2016455_CR14","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1002\/path.4353","volume":"233","author":"CA Sherman-Baust","year":"2014","unstructured":"Sherman-Baust CA, Kuhn E, Valle BL, Shih Ie M, Kurman RJ, Wang TL et al. A genetically engineered ovarian cancer mouse model based on fallopian tube transformation mimics human high-grade serous carcinoma development. J Pathol 2014; 233: 228\u2013237.","journal-title":"J Pathol"},{"key":"BFonc2016455_CR15","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1002\/ijc.29528","volume":"137","author":"SM Quartuccio","year":"2015","unstructured":"Quartuccio SM, Karthikeyan S, Eddie SL, Lantvit DD, Oh E, Modi DA et al. Mutant p53 expression in fallopian tube epithelium drives cell migration. Int J Cancer 2015; 137: 1528\u20131538.","journal-title":"Int J Cancer"},{"key":"BFonc2016455_CR16","doi-asserted-by":"publisher","first-page":"154","DOI":"10.3389\/fonc.2015.00154","volume":"5","author":"MP Endsley","year":"2015","unstructured":"Endsley MP, Moyle-Heyrman G, Karthikeyan S, Lantvit DD, Davis DA, Wei JJ et al. Spontaneous transformation of murine oviductal epithelial cells: a model system to investigate the onset of fallopian-derived tumors. Front Oncol 2015; 5: 154.","journal-title":"Front Oncol"},{"key":"BFonc2016455_CR17","first-page":"463","volume":"43","author":"GR Dressler","year":"1999","unstructured":"Dressler GR, Woolf AS . Pax2 in development and renal disease. Int J Dev Biol 1999; 43: 463\u2013468.","journal-title":"Int J Dev Biol"},{"key":"BFonc2016455_CR18","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1242\/dev.109.4.787","volume":"109","author":"GR Dressler","year":"1990","unstructured":"Dressler GR, Deutsch U, Chowdhury K, Nornes HO, Gruss P . Pax2, a new murine paired-box-containing gene and its expression in the developing excretory system. Development 1990; 109: 787\u2013795.","journal-title":"Development"},{"key":"BFonc2016455_CR19","doi-asserted-by":"publisher","first-page":"2741","DOI":"10.1093\/nar\/28.14.2741","volume":"28","author":"MS Lechner","year":"2000","unstructured":"Lechner MS, Levitan I, Dressler GR . PTIP, a novel BRCT domain-containing protein interacts with Pax2 and is associated with active chromatin. Nucleic Acids Res 2000; 28: 2741\u20132751.","journal-title":"Nucleic Acids Res"},{"key":"BFonc2016455_CR20","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1016\/j.devcel.2007.09.004","volume":"13","author":"SR Patel","year":"2007","unstructured":"Patel SR, Kim D, Levitan I, Dressler GR . The BRCT-domain containing protein PTIP links PAX2 to a histone H3, lysine 4 methyltransferase complex. Dev Cell 2007; 13: 580\u2013592.","journal-title":"Dev Cell"},{"key":"BFonc2016455_CR21","doi-asserted-by":"publisher","first-page":"18078","DOI":"10.1074\/jbc.M109.002527","volume":"284","author":"J Wu","year":"2009","unstructured":"Wu J, Prindle MJ, Dressler GR, Yu X . PTIP regulates 53BP1 and SMC1 at the DNA damage sites. J Biol Chem 2009; 284: 18078\u201318084.","journal-title":"J Biol Chem"},{"key":"BFonc2016455_CR22","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1002\/path.4417","volume":"234","author":"G Ning","year":"2014","unstructured":"Ning G, Bijron JG, Yamamoto Y, Wang X, Howitt BE, Herfs M et al. The PAX2-null immunophenotype defines multiple lineages with common expression signatures in benign and neoplastic oviductal epithelium. J Pathol 2014; 234: 478\u2013487.","journal-title":"J Pathol"},{"key":"BFonc2016455_CR23","doi-asserted-by":"publisher","first-page":"6090","DOI":"10.3390\/ijms14036090","volume":"14","author":"H Song","year":"2013","unstructured":"Song H, Kwan SY, Izaguirre DI, Zu Z, Tsang YT, Tung CS et al. PAX2 Expression in Ovarian Cancer. Int J Mol Sci 2013; 14: 6090\u20136105.","journal-title":"Int J Mol Sci"},{"key":"BFonc2016455_CR24","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1038\/modpathol.2011.175","volume":"25","author":"CM Quick","year":"2012","unstructured":"Quick CM, Ning G, Bijron J, Laury A, Wei TS, Chen EY et al. PAX2-null secretory cell outgrowths in the oviduct and their relationship to pelvic serous cancer. Mod Pathol 2012; 25: 449\u2013455.","journal-title":"Mod Pathol"},{"key":"BFonc2016455_CR25","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1158\/1940-6207.CAPR-15-0121-T","volume":"8","author":"EM Al-Hujaily","year":"2015","unstructured":"Al-Hujaily EM, Tang Y, Yao DS, Carmona E, Garson K, Vanderhyden BC . Divergent roles of PAX2 in the etiology and progression of ovarian cancer. Cancer Prev Res (Phila) 2015; 8: 1163\u20131173.","journal-title":"Cancer Prev Res (Phila)"},{"key":"BFonc2016455_CR26","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1093\/nar\/30.1.207","volume":"30","author":"R Edgar","year":"2002","unstructured":"Edgar R, Domrachev M, Lash AE . Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res 2002; 30: 207\u2013210.","journal-title":"Nucleic Acids Res"},{"key":"BFonc2016455_CR27","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1002\/path.4649","volume":"238","author":"Y Yamamoto","year":"2016","unstructured":"Yamamoto Y, Ning G, Howitt BE, Mehra K, Wu L, Wang X et al. In vitro and in vivo correlates of physiological and neoplastic human Fallopian tube stem cells. J Pathol 2016; 238: 519\u2013530.","journal-title":"J Pathol"},{"key":"BFonc2016455_CR28","doi-asserted-by":"publisher","first-page":"e82241","DOI":"10.1371\/journal.pone.0082241","volume":"8","author":"B Gyorffy","year":"2013","unstructured":"Gyorffy B, Surowiak P, Budczies J, Lanczky A . Online survival analysis software to assess the prognostic value of biomarkers using transcriptomic data in non-small-cell lung cancer. PLoS One 2013; 8: e82241.","journal-title":"PLoS One"},{"key":"BFonc2016455_CR29","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1002\/ijc.29528","volume":"137","author":"SM Quartuccio","year":"2015","unstructured":"Quartuccio SM, Karthikeyan S, Eddie SL, Lantvit DD, \u00d3h E, Modi DA et al. Mutant p53 expression in fallopian tube epithelium drives cell migration. Int J Cancer 2015; 137: 1528\u20131538.","journal-title":"Int J Cancer"},{"key":"BFonc2016455_CR30","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.ygyno.2011.05.021","volume":"123","author":"AM Karst","year":"2011","unstructured":"Karst AM, Levanon K, Duraisamy S, Liu JF, Hirsch MS, Hecht JL et al. Stathmin 1, a marker of PI3K pathway activation and regulator of microtubule dynamics, is expressed in early pelvic serous carcinomas. Gynecol Oncol 2011; 123: 5\u201312.","journal-title":"Gynecol Oncol"},{"key":"BFonc2016455_CR31","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.ygyno.2015.07.100","volume":"139","author":"M Novak","year":"2015","unstructured":"Novak M, Lester J, Karst AM, Parkash V, Hirsch MS, Crum CP et al. Stathmin 1 and p16(INK4A) are sensitive adjunct biomarkers for serous tubal intraepithelial carcinoma. Gynecol Oncol 2015; 139: 104\u2013111.","journal-title":"Gynecol Oncol"},{"key":"BFonc2016455_CR32","doi-asserted-by":"publisher","first-page":"6225","DOI":"10.1158\/0008-5472.CAN-10-0149","volume":"70","author":"NM Monte","year":"2010","unstructured":"Monte NM, Webster KA, Neuberg D, Dressler GR, Mutter GL . Joint loss of PAX2 and PTEN expression in endometrial precancers and cancer. Cancer Res 2010; 70: 6225\u20136232.","journal-title":"Cancer Res"},{"key":"BFonc2016455_CR33","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1038\/nature10166","volume":"474","author":"The Cancer Genome Atlas Research Network","year":"2011","unstructured":"The Cancer Genome Atlas Research Network. Integrated genomic analyses of ovarian carcinoma. Nature 2011; 474: 609\u2013615.","journal-title":"Nature"},{"key":"BFonc2016455_CR34","doi-asserted-by":"publisher","first-page":"25472","DOI":"10.1074\/jbc.273.39.25472","volume":"273","author":"CK Stayner","year":"1998","unstructured":"Stayner CK, Cunliffe HE, Ward TA, Eccles MR . Cloning and characterization of the human PAX2 promoter. J Biol Chem 1998; 273: 25472\u201325479.","journal-title":"J Biol Chem"},{"key":"BFonc2016455_CR35","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.ydbio.2003.11.002","volume":"267","author":"SR Patel","year":"2004","unstructured":"Patel SR, Dressler GR . Expression of Pax2 in the intermediate mesoderm is regulated by YY1. Dev Biol. 2004; 267: 505\u2013516.","journal-title":"Dev Biol."},{"key":"BFonc2016455_CR36","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1038\/modpathol.2010.119","volume":"23","author":"MH Roh","year":"2010","unstructured":"Roh MH, Yassin Y, Miron A, Mehra KK, Mehrad M, Monte NM et al. High-grade fimbrial-ovarian carcinomas are unified by altered p53, PTEN and PAX2 expression. Mod Pathol. 2010; 23: 1316\u20131324.","journal-title":"Mod Pathol."},{"key":"BFonc2016455_CR37","doi-asserted-by":"publisher","first-page":"6225","DOI":"10.1158\/0008-5472.CAN-10-0149","volume":"70","author":"NM Monte","year":"2010","unstructured":"Monte NM, Webster KA, Neuberg D, Dressler GR, Mutter GL . Joint loss of PAX2 and PTEN expression in endometrial precancers and cancer. Cancer Res 2010; 70: 6225\u20136232.","journal-title":"Cancer Res"},{"key":"BFonc2016455_CR38","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1038\/onc.2009.402","volume":"29","author":"K Levanon","year":"2010","unstructured":"Levanon K, Ng V, Piao HY, Zhang Y, Chang MC, Roh MH et al. Primary ex vivo cultures of human fallopian tube epithelium as a model for serous ovarian carcinogenesis. Oncogene 2010; 29: 1103\u20131113.","journal-title":"Oncogene"},{"key":"BFonc2016455_CR39","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.ccr.2004.11.025","volume":"7","author":"G Baldassarre","year":"2005","unstructured":"Baldassarre G, Belletti B, Nicoloso MS, Schiappacassi M, Vecchione A, Spessotto P et al. p27(Kip1)-stathmin interaction influences sarcoma cell migration and invasion. Cancer Cell. 2005; 7: 51\u201363.","journal-title":"Cancer Cell."},{"key":"BFonc2016455_CR40","first-page":"6864","volume":"62","author":"E Alli","year":"2002","unstructured":"Alli E, Bash-Babula J, Yang JM, Hait WN . Effect of stathmin on the sensitivity to antimicrotubule drugs in human breast cancer. Cancer Res 2002; 62: 6864\u20136869.","journal-title":"Cancer Res"},{"key":"BFonc2016455_CR41","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1586\/14737140.8.9.1461","volume":"8","author":"S Rana","year":"2008","unstructured":"Rana S, Maples PB, Senzer N, Nemunaitis J . Stathmin 1: a novel therapeutic target for anticancer activity. Expert Rev Anticancer Ther. 2008; 8: 1461\u20131470.","journal-title":"Expert Rev Anticancer Ther."},{"key":"BFonc2016455_CR42","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1038\/nature10166","volume":"474","author":"Cancer Genome Atlas Research Network.","year":"2011","unstructured":"Cancer Genome Atlas Research Network.. Integrated genomic analyses of ovarian carcinoma. Nature 2011; 474: 609\u2013615.","journal-title":"Nature"},{"key":"BFonc2016455_CR43","doi-asserted-by":"publisher","first-page":"634","DOI":"10.2174\/156800908786241050","volume":"8","author":"Y Lin","year":"2008","unstructured":"Lin Y, Shi R, Wang X, Shen HM . Luteolin, a flavonoid with potential for cancer prevention and therapy. Curr Cancer Drug Targets 2008; 8: 634\u2013646.","journal-title":"Curr Cancer Drug Targets"},{"key":"BFonc2016455_CR44","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1111\/j.1365-2567.2005.02156.x","volume":"115","author":"JS Kim","year":"2005","unstructured":"Kim JS, Jobin C . The flavonoid luteolin prevents lipopolysaccharide-induced NF-kappaB signalling and gene expression by blocking IkappaB kinase activity in intestinal epithelial cells and bone-marrow derived dendritic cells. Immunology 2005; 115: 375\u2013387.","journal-title":"Immunology"},{"key":"BFonc2016455_CR45","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1074\/jbc.M109663200","volume":"277","author":"Y Cai","year":"2002","unstructured":"Cai Y, Lechner MS, Nihalani D, Prindle MJ, Holzman LB, Dressler GR . Phosphorylation of Pax2 by the c-Jun N-terminal kinase and enhanced Pax2-dependent transcription activation. J Biol Chem 2002; 277: 1217\u20131222.","journal-title":"J Biol Chem"},{"key":"BFonc2016455_CR46","doi-asserted-by":"publisher","first-page":"e44869","DOI":"10.1371\/journal.pone.0044869","volume":"7","author":"Z Saifudeen","year":"2012","unstructured":"Saifudeen Z, Liu J, Dipp S, Yao X, Li Y, McLaughlin N et al. A p53-Pax2 pathway in kidney development: implications for nephrogenesis. PLoS One 2012; 7: e44869.","journal-title":"PLoS One"},{"key":"BFonc2016455_CR47","doi-asserted-by":"publisher","first-page":"3842","DOI":"10.1158\/0008-5472.CAN-13-1079","volume":"75","author":"S Zhang","year":"2015","unstructured":"Zhang S, Zhou L, Hong B, van den Heuvel AP, Prabhu VV, Warfel NA et al. Small-Molecule NSC59984 Restores p53 Pathway Signaling and Antitumor Effects against Colorectal Cancer via p73 Activation and Degradation of Mutant p53. Cancer Res 2015; 75: 3842\u20133852.","journal-title":"Cancer Res"},{"key":"BFonc2016455_CR48","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1093\/carcin\/bgt003","volume":"34","author":"SM King","year":"2013","unstructured":"King SM, Quartuccio SM, Vanderhyden BC, Burdette JE . Early transformative changes in normal ovarian surface epithelium induced by oxidative stress require Akt upregulation, DNA damage and epithelial-stromal interaction. Carcinogenesis 2013; 34: 1125\u20131133.","journal-title":"Carcinogenesis"},{"key":"BFonc2016455_CR49","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.ygyno.2015.05.040","volume":"138","author":"AK Mitra","year":"2015","unstructured":"Mitra AK, Davis DA, Tomar S, Roy L, Gurler H, Xie J et al. In vivo tumor growth of high-grade serous ovarian cancer cell lines. Gynecol Oncol 2015; 138: 372\u2013377.","journal-title":"Gynecol Oncol"},{"key":"BFonc2016455_CR50","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1530\/ERC-11-0107","volume":"18","author":"SM King","year":"2011","unstructured":"King SM, Hilliard TS, Wu LY, Jaffe RC, Fazleabas AT, Burdette JE . The impact of ovulation on fallopian tube epithelial cells: evaluating three hypotheses connecting ovulation and serous ovarian cancer. Endocr Relat Cancer 2011; 18: 627\u2013642.","journal-title":"Endocr Relat Cancer"},{"key":"BFonc2016455_CR51","doi-asserted-by":"publisher","first-page":"4762","DOI":"10.3390\/ijms14034762","volume":"14","author":"TS Hilliard","year":"2013","unstructured":"Hilliard TS, Modi DA, Burdette JE . Gonadotropins activate oncogenic pathways to enhance proliferation in normal mouse ovarian surface epithelium. Int J Mol Sci 2013; 14: 4762\u20134782.","journal-title":"Int J Mol Sci"},{"key":"BFonc2016455_CR52","doi-asserted-by":"publisher","first-page":"5299","DOI":"10.1158\/0008-5472.CAN-15-1582","volume":"75","author":"D Vasudevan","year":"2015","unstructured":"Vasudevan D, Hickok JR, Bovee RC, Pham V, Mantell LL, Bahroos N et al. Nitric Oxide Regulates Gene Expression in Cancers by Controlling Histone Posttranslational Modifications. Cancer Res 2015; 75: 5299\u20135308.","journal-title":"Cancer Res"},{"key":"BFonc2016455_CR53","doi-asserted-by":"publisher","first-page":"2304","DOI":"10.1021\/bc2003555","volume":"22","author":"PA Sukerkar","year":"2011","unstructured":"Sukerkar PA, MacRenaris KW, Townsend TR, Ahmed RA, Burdette JE, Meade TJ . Synthesis and biological evaluation of water-soluble progesterone-conjugated probes for magnetic resonance imaging of hormone related cancers. Bioconjug Chem 2011; 22: 2304\u20132316.","journal-title":"Bioconjug Chem"},{"key":"BFonc2016455_CR54","doi-asserted-by":"publisher","first-page":"32785","DOI":"10.18632\/oncotarget.9051","volume":"7","author":"LH Rodgers","year":"2016","unstructured":"Rodgers LH, Oh E, Young AN, Burdette JE . Loss of PAX8 in high-grade serous ovarian cancer reduces cell survival despite unique modes of action in the fallopian tube and ovarian surface epithelium. Oncotarget 2016; 7: 32785\u201332795.","journal-title":"Oncotarget"},{"key":"BFonc2016455_CR55","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s12885-015-1988-0","volume":"16","author":"WL Chen","year":"2016","unstructured":"Chen WL, Pan L, Kinghorn AD, Swanson SM, Burdette JE . Silvestrol induces early autophagy and apoptosis in human melanoma cells. BMC cancer 2016; 16: 17.","journal-title":"BMC cancer"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/onc2016455","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/onc2016455.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/onc.2016.455","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/www.nature.com\/articles\/onc2016455.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,21]],"date-time":"2022-03-21T20:08:42Z","timestamp":1647893322000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/onc2016455"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12,19]]},"references-count":55,"journal-issue":{"issue":"21","published-print":{"date-parts":[[2017,5,25]]}},"alternative-id":["BFonc2016455"],"URL":"https:\/\/doi.org\/10.1038\/onc.2016.455","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,12,19]]},"assertion":[{"value":"20 May 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 November 2016","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 November 2016","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2016","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}